Current, Upcoming, and Past
COA Initiatives
COA's initiatives focus on advancing chromophobe RCC research and enhancing support for patients and researchers in the field.
Open to Apply
Chromophobe Scholar in Training Award
OpenCOA is excited to be a part of the kidney cancer collective, a group of nonprofits and foundations working together to advance research for kidney cancer by collaborating with the American Association for Cancer Research (AACR) to fund a group of Scholar in Training Awards focused on kidney cancer. COA is proud to be supporting the chromophobe award in this inaugural year. This award will help cover the travel costs for a young investigator to attend AACR's Annual Meeting, where they will share their research, network with AACR SITA awardees across cancer types, and be connected with other kidney cancer organizations to set them up with a network for success. The American Association for Cancer Research (AACR) is the largest professional organization for cancer research and we could not be more excited to support this initiative.
In Progress
Chromophobe RCC Focused Research Grant
The chromophobe RCC focused research grant is $75,000 a grant in partnership with the Kidney Cancer Association (KCA) to fund research focused on chromophobe renal cell carcinoma (chRCC). This grant helped fund research focused on chRCC with the goal of advancing research and improving outcomes for patients with this rare kidney cancer. The grant was open for applications in March of 2024 and the recipient was announced in October of 2024. The selected grantee was Dr. Elizabeth Ellis from MD Anderson Cancer Center.
Upcoming
Chromophobe Patient Registry
A patient registry for chromophobe renal cell carcinoma (chRCC) is a database that collects and organizes important information from people diagnosed with this rare kidney cancer. It includes details about patients, their treatments, outcomes, and quality of life. By bringing all this data together, the registry becomes a powerful tool for researchers studying chRCC patterns, doctors comparing treatment approaches, and patients seeking insights from others with the same diagnosis. It transforms individual experiences into a broader understanding of chRCC, potentially leading to improved care strategies and new research directions that could benefit all patients.
Past
Our First Year - Impact Report
In the past year, the Chromophobe Oncology Alliance (COA) has made significant strides in raising awareness and funding for chromophobe renal cell carcinoma (chRCC), a rare kidney cancer. With the support of our community, we raised over $34,700 and reached more than 3 million people through social media efforts. Our partnerships with organizations like the Kidney Cancer Association have enabled us to amplify our impact, including the announcement of our first grant of $75,000 for chRCC research in 2024. This report highlights our achievements, community engagement, and the importance of every contribution in driving advancements in research and support for those affected by chRCC. Join us in celebrating our progress and continuing the fight for a hopeful future.